483 lines
No EOL
89 KiB
HTML
483 lines
No EOL
89 KiB
HTML
<?xml version="1.0" encoding="utf-8"?>
|
||
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
|
||
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
|
||
|
||
<head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
|
||
<!-- AppResources meta begin -->
|
||
<meta name="paf-app-resources" content="" />
|
||
<script type="text/javascript">var ncbi_startTime = new Date();</script>
|
||
|
||
<!-- AppResources meta end -->
|
||
|
||
<!-- TemplateResources meta begin -->
|
||
<meta name="paf_template" content="" />
|
||
|
||
<!-- TemplateResources meta end -->
|
||
|
||
<!-- Logger begin -->
|
||
<meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK143547" /><meta name="ncbi_domain" content="mlprobe" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK143547/" /><meta name="ncbi_pagename" content="Non-covalent triazole-based inhibitors of the SARS main proteinase 3CLpro - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
|
||
<!-- Logger end -->
|
||
|
||
<title>Non-covalent triazole-based inhibitors of the SARS main proteinase 3CLpro - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf</title>
|
||
|
||
<!-- AppResources external_resources begin -->
|
||
<link rel="stylesheet" href="/core/jig/1.15.2/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.15.2/js/jig.min.js"></script>
|
||
|
||
<!-- AppResources external_resources end -->
|
||
|
||
<!-- Page meta begin -->
|
||
<meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="Probe Reports from the NIH Molecular Libraries Program [Internet]" /><meta name="citation_title" content="Non-covalent triazole-based inhibitors of the SARS main proteinase 3CLpro" /><meta name="citation_publisher" content="National Center for Biotechnology Information (US)" /><meta name="citation_date" content="2013/03/14" /><meta name="citation_author" content="Mark Turlington" /><meta name="citation_author" content="Aspen Chun" /><meta name="citation_author" content="Jon Jacobs" /><meta name="citation_author" content="Eric Dawson" /><meta name="citation_author" content="J. Scott Daniels" /><meta name="citation_author" content="Adrian Saldanha" /><meta name="citation_author" content="Peter Chase" /><meta name="citation_author" content="Peter Hodder" /><meta name="citation_author" content="Aimee Eggler" /><meta name="citation_author" content="Valerie Tokars" /><meta name="citation_author" content="Andrew Mesecar" /><meta name="citation_author" content="Craig W. Lindsley" /><meta name="citation_author" content="Shaun R. Stauffer" /><meta name="citation_pmid" content="23762941" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK143547/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Non-covalent triazole-based inhibitors of the SARS main proteinase 3CLpro" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="National Center for Biotechnology Information (US)" /><meta name="DC.Contributor" content="Mark Turlington" /><meta name="DC.Contributor" content="Aspen Chun" /><meta name="DC.Contributor" content="Jon Jacobs" /><meta name="DC.Contributor" content="Eric Dawson" /><meta name="DC.Contributor" content="J. Scott Daniels" /><meta name="DC.Contributor" content="Adrian Saldanha" /><meta name="DC.Contributor" content="Peter Chase" /><meta name="DC.Contributor" content="Peter Hodder" /><meta name="DC.Contributor" content="Aimee Eggler" /><meta name="DC.Contributor" content="Valerie Tokars" /><meta name="DC.Contributor" content="Andrew Mesecar" /><meta name="DC.Contributor" content="Craig W. Lindsley" /><meta name="DC.Contributor" content="Shaun R. Stauffer" /><meta name="DC.Date" content="2013/03/14" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK143547/" /><meta name="description" content="ML300 (CID 46861530) is being declared as a new first in class 3CLpro probe inhibitor. ML300 belongs to a new series of triazole-based SARS main proteinase 3CLpro inhibitors that follow our first dipeptide probe ML188. Based upon X-ray crystal data from a related inhibitor, ML300 is believed to interact within the 3CLpro enzyme active site via a novel binding mode distinct from both our first probe ML188 and other known peptidomimetic inhibitors. Relative to ML188 and based upon X-ray crystal data, the MW of the triazole series described here can be reduced resulting in truncation to a single backbone amide. Structure-activity relationships taking into account ligand efficiency and studies leading to the identification of ML300 will be described. ML300 should allow others in the field to access a novel non-covalent starting point for 3CLpro inhibitor design and optimization." /><meta name="og:title" content="Non-covalent triazole-based inhibitors of the SARS main proteinase 3CLpro" /><meta name="og:type" content="book" /><meta name="og:description" content="ML300 (CID 46861530) is being declared as a new first in class 3CLpro probe inhibitor. ML300 belongs to a new series of triazole-based SARS main proteinase 3CLpro inhibitors that follow our first dipeptide probe ML188. Based upon X-ray crystal data from a related inhibitor, ML300 is believed to interact within the 3CLpro enzyme active site via a novel binding mode distinct from both our first probe ML188 and other known peptidomimetic inhibitors. Relative to ML188 and based upon X-ray crystal data, the MW of the triazole series described here can be reduced resulting in truncation to a single backbone amide. Structure-activity relationships taking into account ligand efficiency and studies leading to the identification of ML300 will be described. ML300 should allow others in the field to access a novel non-covalent starting point for 3CLpro inhibitor design and optimization." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK143547/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-mlprobe-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/mlprobe/ml300/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK143547/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace} .first-line-outdent .bk_ref {display: inline} .body-content h2, .body-content .h2 {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list .graphic {display:inline-block !important} .temp-labeled-list img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.26/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.26/books.min.js"> </script><meta name="book-collection" content="NONE" />
|
||
|
||
<!-- Page meta end -->
|
||
<link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8B08557D660D510000000000910087.m_13" />
|
||
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4216701/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/4207974/4206132/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3411343/3882866.css" media="print" /></head>
|
||
<body class="book-part">
|
||
<div class="grid">
|
||
<div class="col twelve_col nomargin shadow">
|
||
<!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
|
||
<div class="sysmessages">
|
||
<noscript>
|
||
<p class="nojs">
|
||
<strong>Warning:</strong>
|
||
The NCBI web site requires JavaScript to function.
|
||
<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
|
||
</p>
|
||
</noscript>
|
||
</div>
|
||
<!--/.sysmessage-->
|
||
<div class="wrap">
|
||
<div class="page">
|
||
<div class="top">
|
||
<div id="universal_header">
|
||
<section class="usa-banner">
|
||
<div class="usa-accordion">
|
||
<header class="usa-banner-header">
|
||
<div class="usa-grid usa-banner-inner">
|
||
<img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
|
||
<p>An official website of the United States government</p>
|
||
<button class="non-usa-accordion-button usa-banner-button" aria-expanded="false" aria-controls="gov-banner-top" type="button">
|
||
<span class="usa-banner-button-text">Here's how you know</span>
|
||
</button>
|
||
</div>
|
||
</header>
|
||
<div class="usa-banner-content usa-grid usa-accordion-content" id="gov-banner-top" aria-hidden="true">
|
||
<div class="usa-banner-guidance-gov usa-width-one-half">
|
||
<img class="usa-banner-icon usa-media_block-img" src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg" alt="Dot gov" />
|
||
<div class="usa-media_block-body">
|
||
<p>
|
||
<strong>The .gov means it's official.</strong>
|
||
<br />
|
||
Federal government websites often end in .gov or .mil. Before
|
||
sharing sensitive information, make sure you're on a federal
|
||
government site.
|
||
</p>
|
||
</div>
|
||
</div>
|
||
<div class="usa-banner-guidance-ssl usa-width-one-half">
|
||
<img class="usa-banner-icon usa-media_block-img" src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg" alt="Https" />
|
||
<div class="usa-media_block-body">
|
||
<p>
|
||
<strong>The site is secure.</strong>
|
||
<br />
|
||
The <strong>https://</strong> ensures that you are connecting to the
|
||
official website and that any information you provide is encrypted
|
||
and transmitted securely.
|
||
</p>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
</section>
|
||
<div class="usa-overlay"></div>
|
||
<header class="ncbi-header" role="banner" data-section="Header">
|
||
|
||
<div class="usa-grid">
|
||
<div class="usa-width-one-whole">
|
||
|
||
<div class="ncbi-header__logo">
|
||
<a href="/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
|
||
<img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
|
||
</a>
|
||
</div>
|
||
|
||
<div class="ncbi-header__account">
|
||
<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
|
||
<button id="account_info" class="header-button" style="display:none" aria-controls="account_popup" type="button">
|
||
<span class="fa fa-user" aria-hidden="true">
|
||
<svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" width="20px" height="20px">
|
||
<g style="fill: #fff">
|
||
<ellipse cx="12" cy="8" rx="5" ry="6"></ellipse>
|
||
<path d="M21.8,19.1c-0.9-1.8-2.6-3.3-4.8-4.2c-0.6-0.2-1.3-0.2-1.8,0.1c-1,0.6-2,0.9-3.2,0.9s-2.2-0.3-3.2-0.9 C8.3,14.8,7.6,14.7,7,15c-2.2,0.9-3.9,2.4-4.8,4.2C1.5,20.5,2.6,22,4.1,22h15.8C21.4,22,22.5,20.5,21.8,19.1z"></path>
|
||
</g>
|
||
</svg>
|
||
</span>
|
||
<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
|
||
<span class="sr-only">Show account info</span>
|
||
</button>
|
||
</div>
|
||
|
||
<div class="ncbi-popup-anchor">
|
||
<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
|
||
<div class="ncbi-popup-head">
|
||
<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu" type="button">
|
||
<span class="fa fa-times">
|
||
<svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" width="24px" height="24px">
|
||
<path d="M38 12.83l-2.83-2.83-11.17 11.17-11.17-11.17-2.83 2.83 11.17 11.17-11.17 11.17 2.83 2.83 11.17-11.17 11.17 11.17 2.83-2.83-11.17-11.17z"></path>
|
||
</svg>
|
||
</span>
|
||
<span class="usa-sr-only">Close</span></button>
|
||
<h4>Account</h4>
|
||
</div>
|
||
<div class="account-user-info">
|
||
Logged in as:<br />
|
||
<b><span class="username" id="uname_long">username</span></b>
|
||
</div>
|
||
<div class="account-links">
|
||
<ul class="usa-unstyled-list">
|
||
<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
|
||
<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
|
||
<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
|
||
<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
|
||
</ul>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
|
||
</div>
|
||
</div>
|
||
</header>
|
||
<div role="navigation" aria-label="access keys">
|
||
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
|
||
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
|
||
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
|
||
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
|
||
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
|
||
</div>
|
||
<section data-section="Alerts">
|
||
<div class="ncbi-alerts-placeholder"></div>
|
||
</section>
|
||
</div>
|
||
<div class="header">
|
||
<div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
|
||
<div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" data-ac_dict="bookshelf-search">Books</option><option value="pubmed">PubMed</option><option value="clinvar">ClinVar</option><option value="refseq" class="last">RefSeq</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="protfam">Protein Family Models</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
|
||
<a href="/books/browse/">Browse Titles</a>
|
||
</li><li>
|
||
<a href="/books/advanced/">Advanced</a>
|
||
</li><li class="help">
|
||
<a href="/books/NBK3833/">Help</a>
|
||
</li><li class="disclaimer">
|
||
<a target="_blank" data-ga-category="literature_resources" data-ga-action="link_click" data-ga-label="disclaimer_link" href="https://www.ncbi.nlm.nih.gov/books/about/disclaimer/">Disclaimer</a>
|
||
</li></ul></div>
|
||
</div>
|
||
|
||
|
||
|
||
<!--<component id="Page" label="headcontent"/>-->
|
||
|
||
</div>
|
||
<div class="content">
|
||
<!-- site messages -->
|
||
<!-- Custom content 1 -->
|
||
<div class="col1">
|
||
|
||
</div>
|
||
|
||
<div class="container">
|
||
<div id="maincontent" class="content eight_col col">
|
||
<!-- Custom content in the left column above book nav -->
|
||
<div class="col2">
|
||
|
||
</div>
|
||
|
||
<!-- Book content -->
|
||
|
||
|
||
<!-- Custom content between navigation and content -->
|
||
<div class="col3">
|
||
|
||
</div>
|
||
|
||
<div class="document">
|
||
<div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010-. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="Table of Contents Page" href="/books/n/mlprobe/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-mlprobe-lrg.png" alt="Cover of Probe Reports from the NIH Molecular Libraries Program" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>Probe Reports from the NIH Molecular Libraries Program [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK143547_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK143547_dtls__"><div>Bethesda (MD): National Center for Biotechnology Information (US); 2010-.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/mlprobe/">Contents</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/mlprobe/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search this book" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search this book" submit="false" style="padding: 0.1em 0.4em;" /></div></form></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/mlprobe/ml302/" title="Previous page in this title">< Prev</a><a class="active page_link next" href="/books/n/mlprobe/ml299/" title="Next page in this title">Next ></a></div></div></div></div></div>
|
||
<div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK143547_"><span class="title" itemprop="name">Non-covalent triazole-based inhibitors of the SARS main proteinase 3CLpro</span></h1><p class="contrib-group"><span itemprop="author">Mark Turlington</span>, <span itemprop="author">Aspen Chun</span>, <span itemprop="author">Jon Jacobs</span>, <span itemprop="author">Eric Dawson</span>, <span itemprop="author">J. Scott Daniels</span>, <span itemprop="author">Adrian Saldanha</span>, <span itemprop="author">Peter Chase</span>, <span itemprop="author">Peter Hodder</span>, <span itemprop="author">Aimee Eggler</span>, <span itemprop="author">Valerie Tokars</span>, <span itemprop="author">Andrew Mesecar</span>, <span itemprop="author">Craig W. Lindsley</span>, and <span itemprop="author">Shaun R. Stauffer</span>.</p><a data-jig="ncbitoggler" href="#__NBK143547_ai__" style="border:0;text-decoration:none">Author Information and Affiliations</a><div style="display:none" class="ui-widget" id="__NBK143547_ai__"><p class="contrib-group"><h4>Authors</h4><span itemprop="author">Mark Turlington</span>,<sup>2</sup> <span itemprop="author">Aspen Chun</span>,<sup>2</sup> <span itemprop="author">Jon Jacobs</span>,<sup>2</sup> <span itemprop="author">Eric Dawson</span>,<sup>2</sup> <span itemprop="author">J. Scott Daniels</span>,<sup>2</sup> <span itemprop="author">Adrian Saldanha</span>,<sup>3</sup> <span itemprop="author">Peter Chase</span>,<sup>3</sup> <span itemprop="author">Peter Hodder</span>,<sup>3</sup> <span itemprop="author">Aimee Eggler</span>,<sup>1</sup> <span itemprop="author">Valerie Tokars</span>,<sup>4</sup> <span itemprop="author">Andrew Mesecar</span>,<sup>1</sup> <span itemprop="author">Craig W. Lindsley</span>,<sup>2</sup> and <span itemprop="author">Shaun R. Stauffer</span><sup>2</sup><sup>,*</sup>.</p><h4>Affiliations</h4><div class="affiliation"><sup>1</sup>
|
||
Purdue University</div><div class="affiliation"><sup>2</sup>
|
||
Vanderbilt Specialized Chemistry Center for Accelerated Probe Development</div><div class="affiliation"><sup>3</sup>
|
||
Scripps Research Institute Molecular Screening Center</div><div class="affiliation"><sup>4</sup>
|
||
Northwestern University</div><div class="affiliation"><sup>*</sup>
|
||
<span class="before-email-separator"></span><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.tlibrednav@reffuats.nuahs" class="oemail">ude.tlibrednav@reffuats.nuahs</a></div></div><p class="small">Received: <span itemprop="datePublished">April 9, 2012</span>; Last Update: <span itemprop="dateModified">March 14, 2013</span>.</p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="_abs_rndgid_" itemprop="description"><p><a href="/pcsubstance/?term=ML300[synonym]" ref="pagearea=abstract&targetsite=entrez&targetcat=term&targettype=pubchem">ML300</a> (CID 46861530) is being declared as a new first in class 3CLpro probe inhibitor. <a href="/pcsubstance/?term=ML300[synonym]" ref="pagearea=abstract&targetsite=entrez&targetcat=term&targettype=pubchem">ML300</a> belongs to a new series of triazole-based SARS main proteinase 3CLpro inhibitors that follow our first dipeptide probe <a href="/pcsubstance/?term=ML188[synonym]" ref="pagearea=abstract&targetsite=entrez&targetcat=term&targettype=pubchem">ML188</a>. Based upon X-ray crystal data from a related inhibitor, <a href="/pcsubstance/?term=ML300[synonym]" ref="pagearea=abstract&targetsite=entrez&targetcat=term&targettype=pubchem">ML300</a> is believed to interact within the 3CLpro enzyme active site via a novel binding mode distinct from both our first probe <a href="/pcsubstance/?term=ML188[synonym]" ref="pagearea=abstract&targetsite=entrez&targetcat=term&targettype=pubchem">ML188</a> and other known peptidomimetic inhibitors. Relative to <a href="/pcsubstance/?term=ML188[synonym]" ref="pagearea=abstract&targetsite=entrez&targetcat=term&targettype=pubchem">ML188</a> and based upon X-ray crystal data, the MW of the triazole series described here can be reduced resulting in truncation to a single backbone amide. Structure-activity relationships taking into account ligand efficiency and studies leading to the identification of <a href="/pcsubstance/?term=ML300[synonym]" ref="pagearea=abstract&targetsite=entrez&targetcat=term&targettype=pubchem">ML300</a> will be described. <a href="/pcsubstance/?term=ML300[synonym]" ref="pagearea=abstract&targetsite=entrez&targetcat=term&targettype=pubchem">ML300</a> should allow others in the field to access a novel non-covalent starting point for 3CLpro inhibitor design and optimization.</p></div><div class="h2"></div><p><b>Assigned Assay Grant #:</b> <a href="/nuccore/1365502107" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=nuccore">MH084162</a></p><p><b>Screening Center Name & PI:</b> Scripps Research Institute Molecular Screening Center, Hugh Rosen</p><p><b>Chemistry Center Name & PI:</b> Vanderbilt Specialized Chemistry Center for Accelerated Probe Development, Craig W. Lindsley</p><p><b>Assay Submitter & Institution:</b> Andrew Mesecar, Purdue University</p><p><b>PubChem Summary Bioassay Identifier (AID):</b>
|
||
<a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1859" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">1859</a></p><div id="ml300.s1"><h2 id="_ml300_s1_">Probe Structure & Characteristics</h2><div id="ml300.fu1" class="figure"><div class="graphic"><img src="/books/NBK143547/bin/ml300fu1.jpg" alt="Image ml300fu1" /></div></div><div id="ml300.tu1" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK143547/table/ml300.tu1/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ml300.tu1_lrgtbl__"><table><thead><tr><th id="hd_h_ml300.tu1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CID/ML#</th><th id="hd_h_ml300.tu1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Target Name</th><th id="hd_h_ml300.tu1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">IC<sub>50</sub>/EC<sub>50</sub>(nM) [SID, AID]</th><th id="hd_h_ml300.tu1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Anti-target Name(s)</th><th id="hd_h_ml300.tu1_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">IC<sub>50</sub>/EC<sub>50</sub> (μM) [SID, AID]</th><th id="hd_h_ml300.tu1_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Fold Selective</th><th id="hd_h_ml300.tu1_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Secondary Assay(s) Name: IC<sub>50</sub>/EC<sub>50</sub> (nM) [SID, AID]§</th></tr></thead><tbody><tr><td headers="hd_h_ml300.tu1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CID 46861530/<a href="/pcsubstance/?term=ML300[synonym]" ref="pagearea=body&targetsite=entrez&targetcat=term&targettype=pubchem">ML300</a></td><td headers="hd_h_ml300.tu1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">3CLpro</td><td headers="hd_h_ml300.tu1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">1500 [<a href="https://pubchem.ncbi.nlm.nih.gov/substance/99289112" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">SID 99289112</a>,<a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/488967" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">AID 488967</a>, <a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/488958" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">AID 488958</a>]</td><td headers="hd_h_ml300.tu1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">none</td><td headers="hd_h_ml300.tu1_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">IC<sub>50</sub> = 4.11±0.24</td><td headers="hd_h_ml300.tu1_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">NA</td><td headers="hd_h_ml300.tu1_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">NA</td></tr></tbody></table></div></div></div><div id="ml300.s2"><h2 id="_ml300_s2_">1. Recommendations for Scientific Use of the Probe</h2><p>This probe (<a href="/pcsubstance/?term=ML300[synonym]" ref="pagearea=body&targetsite=entrez&targetcat=term&targettype=pubchem">ML300</a>, CID 46861530) represents a second class of non-covalent small molecule inhibitors of the SARS main proteinase 3CLpro using a simple dipeptide backbone. This probe possesses excellent selectivity versus a large panel of GPCRs, ion channels and transporters. In addition, based upon X-ray crystallography data of 3CLpro bound inhibitor <a href="https://pubchem.ncbi.nlm.nih.gov/substance/24808289" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">SID 24808289</a> from the <a href="/pcsubstance/?term=ML300[synonym]" ref="pagearea=body&targetsite=entrez&targetcat=term&targettype=pubchem">ML300</a> series, this probe displays a novel mode of inhibition at the active site distinct from our previous probe <a href="/pcsubstance/?term=ML188[synonym]" ref="pagearea=body&targetsite=entrez&targetcat=term&targettype=pubchem">ML188</a>. As a result of the unique interaction and SAR observed against 3CLpro by <a href="/pcsubstance/?term=ML300[synonym]" ref="pagearea=body&targetsite=entrez&targetcat=term&targettype=pubchem">ML300</a> within this triazole, a unique opportunity to identify potent inhibitors of 3CLpro and potentially related PL enzymes from other coronavirus strains exists. To date, the coronavirus 3CL/PL field has been limited by probes which are high MW peptidomimetics with weak inhibition of 3CLpro and/or probes containing reactive covalent modifier groups. <a href="/pcsubstance/?term=ML300[synonym]" ref="pagearea=body&targetsite=entrez&targetcat=term&targettype=pubchem">ML300</a> does not contain any apparent reactive functional groups and contains only one backbone amide, an improvement over the initial triazole lead <a href="https://pubchem.ncbi.nlm.nih.gov/substance/24808289" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">SID 24808289</a>, which contains two backbone amides occupying four residue pockets of the enzyme. Further, cellular studies using <a href="/pcsubstance/?term=ML300[synonym]" ref="pagearea=body&targetsite=entrez&targetcat=term&targettype=pubchem">ML300</a> will provide insight into their potential relative to existing tool compounds including <a href="/pcsubstance/?term=ML188[synonym]" ref="pagearea=body&targetsite=entrez&targetcat=term&targettype=pubchem">ML188</a>.</p><p>In addition to structural insights provided by <a href="/pcsubstance/?term=ML188[synonym]" ref="pagearea=body&targetsite=entrez&targetcat=term&targettype=pubchem">ML188</a>, we believe the SAR and structure details provided by the <a href="/pcsubstance/?term=ML300[synonym]" ref="pagearea=body&targetsite=entrez&targetcat=term&targettype=pubchem">ML300</a> analog <a href="https://pubchem.ncbi.nlm.nih.gov/substance/24808289" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">SID 24808289</a> will provide a means upon which to facilitate rapid structure-based inhibitor optimization. In addition, this probe will be of use in examining its activity against other emerging CoV strains expressing 3CLpro. This includes the recently identified SAR-like virus called HCoV-EMC, which has been shown to be lethal in the few cases reported to date.</p></div><div id="ml300.s3"><h2 id="_ml300_s3_">2. Materials and Methods</h2><div id="ml300.s4"><h3>2.1. Assays</h3><div id="ml300.tu2" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK143547/table/ml300.tu2/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ml300.tu2_lrgtbl__"><table><thead><tr><th id="hd_h_ml300.tu2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">AID</th><th id="hd_h_ml300.tu2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Name</th></tr></thead><tbody><tr><td headers="hd_h_ml300.tu2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1706" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">AID 1706</a></td><td headers="hd_h_ml300.tu2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the SARS coronavirus 3C-like Protease (3CLPro)</td></tr><tr><td headers="hd_h_ml300.tu2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1859" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">AID 1859</a></td><td headers="hd_h_ml300.tu2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Summary of probe development efforts to identify inhibitors of the SARS coronavirus 3C-like Protease (3CLPro)</td></tr><tr><td headers="hd_h_ml300.tu2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1879" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">AID 1879</a></td><td headers="hd_h_ml300.tu2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">QFRET-based confirmation biochemical high throughput screening assay for inhibitors of the SARS coronavirus 3C-like Protease (3CLPro)</td></tr><tr><td headers="hd_h_ml300.tu2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1890" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">AID 1890</a></td><td headers="hd_h_ml300.tu2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">QFRET-based dose response biochemical high throughput screening assay to identify inhibitors of the SARS coronavirus 3C-like Protease (3CLPro)</td></tr><tr><td headers="hd_h_ml300.tu2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1944" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">AID 1944</a></td><td headers="hd_h_ml300.tu2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Luminescence-based counterscreen for inhibitors of the SARS coronavirus 3C-like Protease (3CLPro): dose response biochemical high throughput screening assay to identify inhibitors of the papain-like protease</td></tr><tr><td headers="hd_h_ml300.tu2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/435015" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">AID 435015</a></td><td headers="hd_h_ml300.tu2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Late stage counterscreen results from the probe development effort to identify inhibitors of the SARS coronavirus 3C-like Protease (3CLPro); luminescence-based cell-based assay to identify cytotoxic compounds in Vero E6 cells.</td></tr><tr><td headers="hd_h_ml300.tu2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/488958" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">AID 488958</a></td><td headers="hd_h_ml300.tu2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Late stage assay provider results from the probe development effort to identify inhibitors of the SARS coronavirus 3C-like Protease (3CLPro): fluorescence-based biochemical dose-response assay for inhibitors of 3CLPro.</td></tr><tr><td headers="hd_h_ml300.tu2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/488877" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">AID 488877</a></td><td headers="hd_h_ml300.tu2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Late stage assay provider counterscreen results from the probe development effort to identify inhibitors of the SARS coronavirus 3C-like Protease (3CLPro): luminescence-based dose-response cell-based assay for restoration of viability of SARS-CoV-infected Vero cells.</td></tr><tr><td headers="hd_h_ml300.tu2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/488967" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">AID 488967</a></td><td headers="hd_h_ml300.tu2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Late stage assay provider results from the probe development effort to identify inhibitors of the SARS coronavirus 3C-like Protease (3CLPro): fluorescence-based biochemical assay for inhibitors of 3CLPro.</td></tr><tr><td headers="hd_h_ml300.tu2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/488984" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">AID 488984</a></td><td headers="hd_h_ml300.tu2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Late stage assay provider results from the probe development effort to identify inhibitors of the SARS coronavirus 3C-like Protease (3CLPro): fluorescence-based biochemical assay for inhibitors of 3CLPro: Set 2</td></tr><tr><td headers="hd_h_ml300.tu2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/493245" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">AID 493245</a></td><td headers="hd_h_ml300.tu2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Late stage assay provider results from the probe development effort to identify inhibitors of the SARS coronavirus 3C-like Protease (3CLPro): fluorescence-based biochemical assay for inhibitors of 3CLPro: Set 3</td></tr><tr><td headers="hd_h_ml300.tu2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/488999" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">AID 488999</a></td><td headers="hd_h_ml300.tu2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Late stage assay provider results from the probe development effort to identify inhibitors of the SARS coronavirus 3C-like Protease (3CLPro): fluorescence-based biochemical dose-response assay for inhibitors of 3CLPro; Set 2</td></tr><tr><td headers="hd_h_ml300.tu2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/588772" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">AID 588772</a></td><td headers="hd_h_ml300.tu2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Late stage assay provider results from the probe development effort to identify inhibitors of the SARS coronavirus 3C-like Protease (3CLPro): fluorescence-based biochemical assay for inhibitors of 3CLPro: Set 4</td></tr><tr><td headers="hd_h_ml300.tu2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/588771" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">AID 588771</a></td><td headers="hd_h_ml300.tu2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Late stage assay provider results from the probe development effort to identify inhibitors of the SARS coronavirus 3C-like Protease (3CLPro): fluorescence-based biochemical dose-response assay for inhibitors of 3CLPro; Set 3.</td></tr><tr><td headers="hd_h_ml300.tu2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/588786" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">AID 588786</a></td><td headers="hd_h_ml300.tu2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Late stage assay provider results from the probe development effort to identify inhibitors of the SARS coronavirus 3C-like Protease (3CLPro): fluorescence-based biochemical dose-response assay for inhibitors of 3CLPro; Set 4.</td></tr><tr><td headers="hd_h_ml300.tu2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/602487" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">AID 602487</a></td><td headers="hd_h_ml300.tu2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Late stage assay provider results from the probe development effort to identify inhibitors of the SARS coronavirus 3C-like Protease (3CLPro): fluorescence-based biochemical assay for inhibitors of 3CLPro: Set 5</td></tr><tr><td headers="hd_h_ml300.tu2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/602486" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">AID 602486</a></td><td headers="hd_h_ml300.tu2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Late stage assay provider results from the probe development effort to identify inhibitors of the SARS coronavirus 3C-like Protease (3CLPro): fluorescence-based biochemical dose-response assay for inhibitors of 3CLPro; Set 5</td></tr></tbody></table></div></div></div><div id="ml300.s5"><h3>2.2. Probe Chemical Characterization</h3><p>Probe compound <a href="/pcsubstance/?term=ML300[synonym]" ref="pagearea=body&targetsite=entrez&targetcat=term&targettype=pubchem">ML300</a> was prepared according to the scheme in <a class="figpopup" href="/books/NBK143547/figure/ml300.f1/?report=objectonly" target="object" rid-figpopup="figml300f1" rid-ob="figobml300f1">Figure 1</a> and provided the following characterization data: LC-MS (>98%) <i>m/z</i> = 432.1 [M+H]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.05 (1H, s), 8.02 (1H, d, J = 8.4 Hz), 7.61 (2H, d, <i>J</i> = 8.6 Hz), 7.49 (2H, m), 7.36 (1H, p, J = 4.2 Hz), 7.23 (1H, m), 7.02 (3H, m), 6.95 (1H, d, <i>J</i> = 4.92 Hz), 5.15 (2H, s), 4.84 (2H, s), 1.55 (1H, m), 1.09 (2H, m), 0.85 (2H, m); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 172.6, 164.9, 145.7, 139.3, 136.7, 134.9, 133.7, 128.7, 128.1, 127.8, 126.2, 124.4, 124.1, 120.9, 119.7, 109.8, 49.7, 48.4, 15.5, 8.2; HRMS (ESI) m/z 432.1497 ([M+H]<sup>+</sup>, 100%) calcd for C<sub>23</sub>H<sub>22</sub>N<sub>5</sub>O<sub>2</sub>S, 432.1494.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figml300f1" co-legend-rid="figlgndml300f1"><a href="/books/NBK143547/figure/ml300.f1/?report=objectonly" target="object" title="Figure 1" class="img_link icnblk_img figpopup" rid-figpopup="figml300f1" rid-ob="figobml300f1"><img class="small-thumb" src="/books/NBK143547/bin/ml300f1.gif" src-large="/books/NBK143547/bin/ml300f1.jpg" alt="Figure 1. Synthetic procedure and spectral data for ML300 (CID 46861530)." /></a><div class="icnblk_cntnt" id="figlgndml300f1"><h4 id="ml300.f1"><a href="/books/NBK143547/figure/ml300.f1/?report=objectonly" target="object" rid-ob="figobml300f1">Figure 1</a></h4><p class="float-caption no_bottom_margin">Synthetic procedure and spectral data for ML300 (CID 46861530). </p></div></div><p><b>Solubility.</b> Solubility in PBS at pH 7.4 was determined to be 29 μM or 13 μg/mL. <a href="/pcsubstance/?term=ML300[synonym]" ref="pagearea=body&targetsite=entrez&targetcat=term&targettype=pubchem">ML300</a> shows good solubility up >100 μM DMSO and up to 40 mM DMSO which is currently used for original stocks of novel compounds shipped to the assay provider for testing. In addition, solubility in organic solvents for <a href="/pcsubstance/?term=ML300[synonym]" ref="pagearea=body&targetsite=entrez&targetcat=term&targettype=pubchem">ML300</a> versus <a href="/pcsubstance/?term=ML188[synonym]" ref="pagearea=body&targetsite=entrez&targetcat=term&targettype=pubchem">ML188</a> appears to be improved.</p><p><b>Stability.</b> Stability was determined for <a href="/pcsubstance/?term=ML300[synonym]" ref="pagearea=body&targetsite=entrez&targetcat=term&targettype=pubchem">ML300</a> in PBS buffer at room temperature with both 5 and 10% DMSO. <a href="/pcsubstance/?term=ML300[synonym]" ref="pagearea=body&targetsite=entrez&targetcat=term&targettype=pubchem">ML300</a> was found to be completely stable (>99% intact) after 48h.</p><p><b>Compounds added to the SMR collection (MLS#s):</b> MLS004084528 (<a href="/pcsubstance/?term=ML300[synonym]" ref="pagearea=body&targetsite=entrez&targetcat=term&targettype=pubchem">ML300</a>, CID 46861530, 20.4 mg); MLS004084529 (CID 46861523, 8.8 mg); MLS004084530 (CID 45382022, 5.5 mg); MLS004084531 (CID 45382030, 7.4 mg); MLS004084532 (CID 46861528, 16.1 mg); MLS004084533 (CID 46861529, 17.6 mg).</p></div><div id="ml300.s6"><h3>2.3. Probe Preparation</h3><div id="ml300.s7"><h4>N-(4-(2-(1H-benzo[d][1,2,3]triazol-1-yl)-N-(thiophen-3- ylmethyl)acetamido)phenyl)cyclopropanecarboxamide (ML300, CID 46861530)</h4><div id="ml300.fu2" class="figure"><div class="graphic"><img src="/books/NBK143547/bin/ml300fu2.jpg" alt="Image ml300fu2" /></div></div><p><b>Step 1: Preparation of tert-butyl (4-((thiophen-3-ylmethyl)amino)phenyl)carbamate.</b> 3-thiophenecarboxylic acid (0.383 mL, 4.4 mmol, 1.0 equiv) and N-Boc-p-phenylenediamine (1.12 g, 5.4 mmol, 1.22 equiv) were dissolved in dichloroethane (44 mL, 0.1 M) in a 100 mL round bottom flask. Sodium triacetoxyborohydride (1.43 g, 6.7 mmol, 1.52 equiv) was added and the reaction was stirred at room temperature for 1 h. The reaction was determined to be complete by LC-MS, quenched with NH<sub>4</sub>Cl (sat’d, aqueous), and extracted with EtOAc (3 × 40 mL). The combined organic layers were dried over MgSO<sub>4</sub>, concentrated, and purified by silica gel column chromatography, eluting with EtOAc/hexanes. The title compound eluted at 35% EtOAc/hexanes and was isolated as a light yellow solid in quantitative yield (1.34 g). LC-MS (>98%) <i>m/z</i> = 305.2 [M+H].</p><div id="ml300.fu3" class="figure"><div class="graphic"><img src="/books/NBK143547/bin/ml300fu3.jpg" alt="Image ml300fu3" /></div></div><p><b>Step 2: Preparation of tert-butyl (4-(2-(1H-benzo[d][1,2,3]triazol-1-yl)-N-(thiophen-3-ylmethyl)acetamido)phenyl)carbamate.</b><i>Tert</i>-butyl (4-((thiophen-3-ylmethyl)amino)phenyl)carbamate (1.1 g, 3.6 mmol, 1.0 equiv) and HATU (1.71 g, 4.5 mmol, 1.25 equiv) were combined in DMF (30 mL, 0.12 M) in a 100 mL round bottom flask. <i>N</i>,<i>N</i>-diisopropylethylamine (1.56 mL, 9 mmol, 2.5 equiv) was added and the reaction was stirred at room temperature for 10 min. 1-Benzotriazolylacetic acid (736 mg, 4.16, 1.15 equiv) was added and the reaction was stirred at room temperature for 16 h after which no further formation of the product was observed by LC-MS. The mixture was diluted with EtOAc (100 mL) and the organic layer was washed with water (3 × 25 mL). The organic layer was dried over MgSO<sub>4,</sub> concentrated under reduced pressure, and purified by silica gel column chromatography eluting with EtOAc/hexanes. The title compound eluted at 50% EtOAc/hexanes and was isolated as an off-white solid in 56% yield (931 mg). LC-MS (>98%) <i>m/z</i> = 464.2 [M+H].</p><div id="ml300.fu4" class="figure"><div class="graphic"><img src="/books/NBK143547/bin/ml300fu4.jpg" alt="Image ml300fu4" /></div></div><p><b>Step 3: Preparation of N-(4-(2-(1H-benzo[d][1,2,3]triazol-1-yl)-N-(thiophen-3-ylmethyl)acetamido)phenyl)cyclopropanecarboxamide.</b><i>Tert</i>-butyl (4-(2-(1H-benzo[d][1,2,3]triazol-1-yl)-N-(thiophen-3-ylmethyl)acetamido)phenyl)carbamate (920 mg, 1.98 mmol, 1.0 equiv) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (3 mL, 0.66 M) in a 20 mL scintillation vial. Trifluoroacetic acid (TFA, 2 mL, 26.1 mmol, 13 equiv) was added, and after stirring at room temperature for 1 h the starting material was determined to be consumed by LC-MS. The solvents were evaporated under reduced pressure and the resulting de-Boc protected aniline was used without purification. LC-MS (>98%) <i>m/z</i> = 364.1 [M+H].</p><p>The aniline (1.98 mmol, 1.0 equiv) was re-dissolved in CH<sub>2</sub>Cl<sub>2</sub> (20 mL, 0.1 M) and Et<sub>3</sub>N (2.48 mL, 17.82 mmol, 9 equiv) was added. (Excess Et<sub>3</sub>N was used to neutralize any residual TFA, and the reaction mixture was determined to be basic by checking with pH paper.) Cyclopropanecarbonyl chloride (0.23 mL, 2.48, 1.25 equiv) was added and the reaction mixture was stirred for 1 h, after which the starting material was determined to be consumed by LC-MS. The reaction was quenched with NH<sub>4</sub>Cl (sat’d aqueous) and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 20 mL). The combined organic layers were dried over MgSO<sub>4</sub>, concentrated, and purified by silica gel column chromatography eluting with EtOAc\hexanes. The title compound eluted at 75% EtOAc/hexanes to yield a tan solid in 39% yield (330 mg). LC-MS (>98%) <i>m/z</i> = 432.1 [M+H]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.05 (1H, s), 8.02 (1H, d, J = 8.4 Hz), 7.61 (2H, d, <i>J</i> = 8.6 Hz), 7.49 (2H, m), 7.36 (1H, p, J = 4.2 Hz), 7.23 (1H, m), 7.02 (3H, m), 6.95 (1H, d, <i>J</i> = 4.92 Hz), 5.15 ( 2H, s), 4.84 (2H, s), 1.55 (1H, m), 1.09 (2H, m), 0.85 (2H, m); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 172.6, 164.9, 145.7, 139.3, 136.7, 134.9, 133.7, 128.7, 128.1, 127.8, 126.2, 124.4, 124.1, 120.9, 119.7, 109.8, 49.7, 48.4, 15.5, 8.2; HRMS (ESI) m/z 432.1497 ([M+H]<sup>+</sup>, 100%) calcd for C<sub>23</sub>H<sub>22</sub>N<sub>5</sub>O<sub>2</sub>S, 432.1494.</p></div></div></div><div id="ml300.s8"><h2 id="_ml300_s8_">3. Results</h2><div id="ml300.s9"><h3>3.1. Dose Response Curves for Probe</h3><div id="ml300.f2" class="figure bk_fig"><div class="graphic"><img src="/books/NBK143547/bin/ml300f2.jpg" alt="Figure 2. M-M Inhibition Curve for ML300." /></div><h3><span class="label">Figure 2</span><span class="title">M-M Inhibition Curve for ML300</span></h3></div></div><div id="ml300.s10"><h3>3.2. Cellular Activity</h3><p>Cellar activity measurements are still in progress using against SARS-CoV Urbani infected Vero E6 cells using <a href="/pcsubstance/?term=ML300[synonym]" ref="pagearea=body&targetsite=entrez&targetcat=term&targettype=pubchem">ML300</a>. Prior studies using <a href="/pcsubstance/?term=ML188[synonym]" ref="pagearea=body&targetsite=entrez&targetcat=term&targettype=pubchem">ML188</a> suggest cellular activity above 10 micromolar is likely for <a href="/pcsubstance/?term=ML300[synonym]" ref="pagearea=body&targetsite=entrez&targetcat=term&targettype=pubchem">ML300</a>. Although it remains to be seen, based on the EC<sub>50</sub>/IC<sub>50</sub> ratio observed for <a href="/pcsubstance/?term=ML188[synonym]" ref="pagearea=body&targetsite=entrez&targetcat=term&targettype=pubchem">ML188</a> (<10) as a minimum, we expect improvements in potency below micromolar level will be required to achieve good cellular activity for the triazole series below 10 μM.</p></div><div id="ml300.s11"><h3>3.3. Profiling Assays</h3><p>The probe molecule (<a href="/pcsubstance/?term=ML188[synonym]" ref="pagearea=body&targetsite=entrez&targetcat=term&targettype=pubchem">ML188</a>) was tested at Ricerca’s (formerly MDS Pharma’s) Lead Profiling Screen (binding assay panel of 68 GPCRs, ion channels and transporters screened at 10 μM), and was found to have one hit against Melatonin (MT1) at 75% inhibition.</p></div></div><div id="ml300.s12"><h2 id="_ml300_s12_">4. Discussion</h2><div id="ml300.s13"><h3>4.1. Comparison to Existing Art and How the New Probe is an Improvement</h3><p>Based on recent literature searches, a lack of legitimate non-covalent 3CLpro inhibitors continues to exist. The field has been limited mostly to covalently bound inhibitors.(<a class="bk_pop" href="#ml300.r1">1</a>–<a class="bk_pop" href="#ml300.r5">5</a> and references therein) Among non-covalent inhibitors to date, these are primarily limited to large refined peptidomimetics with poor inhibitory activity (<a class="bk_pop" href="#ml300.r4">4</a>) or so-called small molecules, that in fact maintain a covalent modifier group or reactive elements that would limit their potential for development as an antiviral. A summary of second generation small molecule 3CLpro inhibitors, some containing reactive warhead groups and are known to have a covalent mode of action, are included in <a class="figpopup" href="/books/NBK143547/figure/ml300.f3/?report=objectonly" target="object" rid-figpopup="figml300f3" rid-ob="figobml300f3">Figure 3</a>.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figml300f3" co-legend-rid="figlgndml300f3"><a href="/books/NBK143547/figure/ml300.f3/?report=objectonly" target="object" title="Figure 3" class="img_link icnblk_img figpopup" rid-figpopup="figml300f3" rid-ob="figobml300f3"><img class="small-thumb" src="/books/NBK143547/bin/ml300f3.gif" src-large="/books/NBK143547/bin/ml300f3.jpg" alt="Figure 3. Second generation small molecule 3CLpro inhibitors." /></a><div class="icnblk_cntnt" id="figlgndml300f3"><h4 id="ml300.f3"><a href="/books/NBK143547/figure/ml300.f3/?report=objectonly" target="object" rid-ob="figobml300f3">Figure 3</a></h4><p class="float-caption no_bottom_margin">Second generation small molecule 3CLpro inhibitors. Some contain reactive warhead groups and are known to have a covalent mode of action </p></div></div><p>This probe molecule (<a href="/pcsubstance/?term=ML300[synonym]" ref="pagearea=body&targetsite=entrez&targetcat=term&targettype=pubchem">ML300</a>) is a non-covalent inhibitor of the SARS-CoV 3CLpro enzyme. It is selective against the related PLpro enzyme. This inhibitor can be synthetically accessed in a straight forward four-step sequence and no chiral chromatography is required. Current inhibitors within the covalent modifier class require multiple steps to access a final compound. The 3CLpro-<a href="/pcsubstance/?term=ML188[synonym]" ref="pagearea=body&targetsite=entrez&targetcat=term&targettype=pubchem">ML188</a> and SID-<a href="https://pubchem.ncbi.nlm.nih.gov/substance/289" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">289</a> X-ray crystal structures were critical in guiding the optimization process and encouraged the exploration of the P3-truncated effort within the benzotriazole series. With this additional probe 3CLpro inhibitor declared, a renewed interest to develop selective small molecule inhibitors against 3CLpro and other coronavirus proteinase targets will follow as the field continues to search for novel antivirals against SARS and SARS-like infections.</p></div></div><div id="ml300.s14"><h2 id="_ml300_s14_">5. References</h2><dl class="temp-labeled-list"><dt>1.</dt><dd><div class="bk_ref" id="ml300.r1">Anand K, Ziebuhr J, Wadhwani R, Mesters JR, Hilgenfeld R. Coronavirus Main Proteinase (3CLpro) Structure: Basis for Design of Anti-SARS Drugs. <span><span class="ref-journal">Science. </span>2003;<span class="ref-vol">300</span>:1763–1767.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12746549" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12746549</span></a>]</div></dd><dt>2.</dt><dd><div class="bk_ref" id="ml300.r2">Ghosh AK, Xi K, Johnson ME, Baker SC, Mesecar AD. Progress in Anti-SARS Coronavirus Chemistry, Biology and Chemotherapy. <span><span class="ref-journal">Ann. Rep. Med. Chem. </span>2006;<span class="ref-vol">41</span>:183–196.</span> [<a href="/pmc/articles/PMC2718771/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC2718771</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19649165" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 19649165</span></a>]</div></dd><dt>3.</dt><dd><div class="bk_ref" id="ml300.r3">Ghosh AK, Gong G, Grum-Tokars V, Mulhearn DC, Baker SC, Coughlin M, Prabhakar BS, Sleeman K, Johnson ME, Mesecar AD. Design, synthesis and antiviral efficacy of a series of potent choropyridyl ester-derived SARS-CoV 3CLpro inhibitors. <span><span class="ref-journal">Bioorg Med Chem Lett. </span>2008;<span class="ref-vol">18</span>:5684–5688.</span> [<a href="/pmc/articles/PMC2745596/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC2745596</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18796354" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 18796354</span></a>]</div></dd><dt>4.</dt><dd><div class="bk_ref" id="ml300.r4">Wu C.-Y, Jan J.-T, Ma S.-H, Kuo C.-J, Juan H.-F, Cheng EY.-S, Hsu H.-H, Huang H.-C, Wu D, Brik A, Liang F.-S, Liu R.-S, Fang J.-M, Chen S.-T, Liang P.-H, Wong C.-H. Small molecules targeting severe acute respiratory syndrome human coronavirus. <span><span class="ref-journal">Proc Natl Acad Sci. </span>2004;<span class="ref-vol">101</span>:10012.</span> [<a href="/pmc/articles/PMC454157/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC454157</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15226499" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 15226499</span></a>]</div></dd><dt>5.</dt><dd><div class="bk_ref" id="ml300.r5">Ghosh AK, Xi K, Ratia K, Santarsiero BD, Fu W, Harcourt BH, Rota PA, Baker SC, Johnson ME, Mesecar AD. Design and Synthesis of Peptidomimetic Severe Acute Respiratory Syndrome Chymotrypsin-like Protease Inhibitors. <span><span class="ref-journal">J Med Chem. </span>2005;<span class="ref-vol">48</span>:6767–6770.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16250632" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 16250632</span></a>]</div></dd></dl></div><div id="bk_toc_contnr"></div></div></div>
|
||
<div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright Notice</a></div><div class="small"><span class="label">Bookshelf ID: NBK143547</span><span class="label">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/23762941" title="PubMed record of this page" ref="pagearea=meta&targetsite=entrez&targetcat=link&targettype=pubmed">23762941</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/mlprobe/">Contents</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/mlprobe/ml302/" title="Previous page in this title">< Prev</a><a class="active page_link next" href="/books/n/mlprobe/ml299/" title="Next page in this title">Next ></a></div></div></div></div>
|
||
|
||
</div>
|
||
|
||
<!-- Custom content below content -->
|
||
<div class="col4">
|
||
|
||
</div>
|
||
|
||
|
||
<!-- Book content -->
|
||
|
||
<!-- Custom contetnt below bottom nav -->
|
||
<div class="col5">
|
||
|
||
</div>
|
||
</div>
|
||
|
||
<div id="rightcolumn" class="four_col col last">
|
||
<!-- Custom content above discovery portlets -->
|
||
<div class="col6">
|
||
<div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK143547&db=books">Share</a></div>
|
||
|
||
</div>
|
||
<div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK143547/?report=reader">PubReader</a></li><li><a href="/books/NBK143547/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK143547" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK143547" style="display:none" title="Cite this Page"><div class="bk_tt">Turlington M, Chun A, Jacobs J, et al. Non-covalent triazole-based inhibitors of the SARS main proteinase 3CLpro. 2012 Apr 9 [Updated 2013 Mar 14]. In: Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010-. <span class="bk_cite_avail"></span></div></div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this Page</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#ml300.s1" ref="log$=inpage&link_id=inpage">Probe Structure & Characteristics</a></li><li><a href="#ml300.s2" ref="log$=inpage&link_id=inpage">Recommendations for Scientific Use of the Probe</a></li><li><a href="#ml300.s3" ref="log$=inpage&link_id=inpage">Materials and Methods</a></li><li><a href="#ml300.s8" ref="log$=inpage&link_id=inpage">Results</a></li><li><a href="#ml300.s12" ref="log$=inpage&link_id=inpage">Discussion</a></li><li><a href="#ml300.s14" ref="log$=inpage&link_id=inpage">References</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&DbFrom=books&Cmd=Link&LinkName=books_pmc_refs&IdsFromResult=3036616" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pcassay&DbFrom=books&Cmd=Link&LinkName=books_pcassay_probe&IdsFromResult=3036616" ref="log$=recordlinks">PubChem BioAssay for Chemical Probe</a><div class="brieflinkpop offscreen_noflow">PubChem BioAssay records reporting screening data for the development of the chemical probe(s) described in this book chapter</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pcsubstance&DbFrom=books&Cmd=Link&LinkName=books_pcsubstance&IdsFromResult=3036616" ref="log$=recordlinks">PubChem Substance</a><div class="brieflinkpop offscreen_noflow">Related PubChem Substances</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&DbFrom=books&Cmd=Link&LinkName=books_pubmed_refs&IdsFromResult=3036616" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23658941" ref="ordinalpos=1&linkpos=1&log$=relatedreviews&logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Discovery of non-covalent inhibitors of the SARS main proteinase 3CLpro.</a><span class="source">[Probe Reports from the NIH Mol...]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Discovery of non-covalent inhibitors of the SARS main proteinase 3CLpro.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Jacobs J, Zhou S, Dawson E, Daniels JS, Hodder P, Tokars V, Mesecar A, Lindsley CW, Stauffer SR. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Probe Reports from the NIH Molecular Libraries Program. 2010</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24080461" ref="ordinalpos=1&linkpos=2&log$=relatedarticles&logdbfrom=pubmed">Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit binding.</a><span class="source">[Bioorg Med Chem Lett. 2013]</span><div class="brieflinkpop offscreen_noflow">Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit binding.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Turlington M, Chun A, Tomar S, Eggler A, Grum-Tokars V, Jacobs J, Daniels JS, Dawson E, Saldanha A, Chase P, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Bioorg Med Chem Lett. 2013 Nov 15; 23(22):6172-7. Epub 2013 Sep 7.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23231439" ref="ordinalpos=1&linkpos=3&log$=relatedarticles&logdbfrom=pubmed">Discovery, synthesis, and structure-based optimization of a series of N-(tert-butyl)-2-(N-arylamido)-2-(pyridin-3-yl) acetamides (ML188) as potent noncovalent small molecule inhibitors of the severe acute respiratory syndrome coronavirus (SARS-CoV) 3CL protease.</a><span class="source">[J Med Chem. 2013]</span><div class="brieflinkpop offscreen_noflow">Discovery, synthesis, and structure-based optimization of a series of N-(tert-butyl)-2-(N-arylamido)-2-(pyridin-3-yl) acetamides (ML188) as potent noncovalent small molecule inhibitors of the severe acute respiratory syndrome coronavirus (SARS-CoV) 3CL protease.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Jacobs J, Grum-Tokars V, Zhou Y, Turlington M, Saldanha SA, Chase P, Eggler A, Dawson ES, Baez-Santos YM, Tomar S, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Med Chem. 2013 Jan 24; 56(2):534-46. Epub 2013 Jan 3.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25694593" ref="ordinalpos=1&linkpos=4&log$=relatedarticles&logdbfrom=pubmed">Broad-spectrum inhibitors against 3C-like proteases of feline coronaviruses and feline caliciviruses.</a><span class="source">[J Virol. 2015]</span><div class="brieflinkpop offscreen_noflow">Broad-spectrum inhibitors against 3C-like proteases of feline coronaviruses and feline caliciviruses.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kim Y, Shivanna V, Narayanan S, Prior AM, Weerasekara S, Hua DH, Kankanamalage AC, Groutas WC, Chang KO. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Virol. 2015 May; 89(9):4942-50. Epub 2015 Feb 18.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/17722874" ref="ordinalpos=1&linkpos=5&log$=relatedreviews&logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Design of HIV protease inhibitors targeting protein backbone: an effective strategy for combating drug resistance.</a><span class="source">[Acc Chem Res. 2008]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Design of HIV protease inhibitors targeting protein backbone: an effective strategy for combating drug resistance.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Ghosh AK, Chapsal BD, Weber IT, Mitsuya H. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Acc Chem Res. 2008 Jan; 41(1):78-86. Epub 2007 Aug 28.</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&cmd=link&linkname=pubmed_pubmed_reviews&uid=23762941" ref="ordinalpos=1&log$=relatedreviews_seeall&logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&cmd=link&linkname=pubmed_pubmed&uid=23762941" ref="ordinalpos=1&log$=relatedarticles_seeall&logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=67d66b7867c23b31e0b185fb">Non-covalent triazole-based inhibitors of the SARS main proteinase 3CLpro - Prob...</a><div class="ralinkpop offscreen_noflow">Non-covalent triazole-based inhibitors of the SARS main proteinase 3CLpro - Probe Reports from the NIH Molecular Libraries Program<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&linkpos=2" href="/portal/utils/pageresolver.fcgi?recordid=67d66b7767c23b31e0b180dd">ML302, a Novel Beta-lactamase (BLA) Inhibitor - Probe Reports from the NIH Molec...</a><div class="ralinkpop offscreen_noflow">ML302, a Novel Beta-lactamase (BLA) Inhibitor - Probe Reports from the NIH Molecular Libraries Program<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&linkpos=3" href="/portal/utils/pageresolver.fcgi?recordid=67d66b762f30673f7bf66b41">Discovery of Small Molecule Influenza Virus NS1 Antagonist - Probe Reports from ...</a><div class="ralinkpop offscreen_noflow">Discovery of Small Molecule Influenza Virus NS1 Antagonist - Probe Reports from the NIH Molecular Libraries Program<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&linkpos=4" href="/portal/utils/pageresolver.fcgi?recordid=67d66b7567c23b31e0b17954">A 2nd Selective Inhibitor of Plasmodium falciparum Glucose-6-Phosphate Dehydroge...</a><div class="ralinkpop offscreen_noflow">A 2nd Selective Inhibitor of Plasmodium falciparum Glucose-6-Phosphate Dehydrogenase (PfG6PDH) - Probe 2 - Probe Reports from the NIH Molecular Libraries Program<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&linkpos=5" href="/portal/utils/pageresolver.fcgi?recordid=67d66b7467c23b31e0b176a9">Discovery of Novel General Anesthetics Using Apoferritin as a Surrogate System -...</a><div class="ralinkpop offscreen_noflow">Discovery of Novel General Anesthetics Using Apoferritin as a Surrogate System - Probe Reports from the NIH Molecular Libraries Program<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
|
||
|
||
<!-- Custom content below discovery portlets -->
|
||
<div class="col7">
|
||
|
||
</div>
|
||
</div>
|
||
</div>
|
||
|
||
<!-- Custom content after all -->
|
||
<div class="col8">
|
||
|
||
</div>
|
||
<div class="col9">
|
||
|
||
</div>
|
||
|
||
<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
|
||
<script type="text/javascript">
|
||
(function($){
|
||
$('.skiplink').each(function(i, item){
|
||
var href = $($(item).attr('href'));
|
||
href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
|
||
$(item).on('click', function(event){
|
||
event.preventDefault();
|
||
$.scrollTo(href, 0, {
|
||
onAfter: function(){
|
||
href.focus();
|
||
}
|
||
});
|
||
});
|
||
});
|
||
})(jQuery);
|
||
</script>
|
||
</div>
|
||
<div class="bottom">
|
||
|
||
<div id="NCBIFooter_dynamic">
|
||
<!--<component id="Breadcrumbs" label="breadcrumbs"/>
|
||
<component id="Breadcrumbs" label="helpdesk"/>-->
|
||
|
||
</div>
|
||
|
||
<div class="footer" id="footer">
|
||
<section class="icon-section">
|
||
<div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
|
||
<div class="grid-container container">
|
||
<div class="icon-section_container">
|
||
<a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg xmlns="http://www.w3.org/2000/svg" data-name="Layer 1" viewBox="0 0 300 300">
|
||
<defs>
|
||
<style>
|
||
.cls-11 {
|
||
fill: #737373;
|
||
}
|
||
</style>
|
||
</defs>
|
||
<title>Twitter</title>
|
||
<path class="cls-11" d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
|
||
</path>
|
||
</svg></a>
|
||
<a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg xmlns="http://www.w3.org/2000/svg" data-name="Layer 1" viewBox="0 0 300 300">
|
||
<title>Facebook</title>
|
||
<path class="cls-11" d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
|
||
</path>
|
||
</svg></a>
|
||
<a class="footer-icon" id="footer_linkedin" href="https://www.linkedin.com/company/ncbinlm" aria-label="LinkedIn"><svg xmlns="http://www.w3.org/2000/svg" data-name="Layer 1" viewBox="0 0 300 300">
|
||
<title>LinkedIn</title>
|
||
<path class="cls-11" d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
|
||
</path>
|
||
</svg></a>
|
||
<a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg xmlns="http://www.w3.org/2000/svg" data-name="Layer 1" viewBox="0 0 300 300">
|
||
<defs>
|
||
<style>
|
||
.cls-11,
|
||
.cls-12 {
|
||
fill: #737373;
|
||
}
|
||
|
||
.cls-11 {
|
||
fill-rule: evenodd;
|
||
}
|
||
</style>
|
||
</defs>
|
||
<title>GitHub</title>
|
||
<path class="cls-11" d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
|
||
</path>
|
||
<path class="cls-12" d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
|
||
</path>
|
||
<path class="cls-12" d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
|
||
</path>
|
||
<path class="cls-12" d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
|
||
<path class="cls-12" d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
|
||
</path>
|
||
<path class="cls-12" d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
|
||
</path>
|
||
<path class="cls-12" d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
|
||
</path>
|
||
<path class="cls-12" d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
|
||
</svg></a>
|
||
<a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
|
||
<svg xmlns="http://www.w3.org/2000/svg" id="Layer_1" data-name="Layer 1" viewBox="0 0 40 40">
|
||
<defs><style>.cls-1{fill:#737373;}</style></defs>
|
||
<title>NCBI Insights Blog</title>
|
||
<path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"></path>
|
||
</svg>
|
||
</a>
|
||
</div>
|
||
</div>
|
||
</section>
|
||
|
||
<section class="container-fluid bg-primary">
|
||
<div class="container pt-5">
|
||
<div class="row mt-3">
|
||
<div class="col-lg-3 col-12">
|
||
<p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
|
||
<ul class="list-inline social_media">
|
||
<li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter" target="_blank" rel="noopener noreferrer"><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" version="1.1" x="0px" y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
|
||
<style type="text/css">
|
||
.st20 {
|
||
fill: #FFFFFF;
|
||
}
|
||
|
||
.st30 {
|
||
fill: none;
|
||
stroke: #FFFFFF;
|
||
stroke-width: 8;
|
||
stroke-miterlimit: 10;
|
||
}
|
||
</style>
|
||
<title>Twitter</title>
|
||
<g>
|
||
<g>
|
||
<g>
|
||
<path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7 c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116 c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3 c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6 C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
|
||
</g>
|
||
</g>
|
||
<circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
|
||
</g>
|
||
</svg></a></li>
|
||
<li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine" aria-label="Facebook" rel="noopener noreferrer" target="_blank">
|
||
<svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" version="1.1" x="0px" y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
|
||
<style type="text/css">
|
||
.st10 {
|
||
fill: #FFFFFF;
|
||
}
|
||
|
||
.st110 {
|
||
fill: none;
|
||
stroke: #FFFFFF;
|
||
stroke-width: 8;
|
||
stroke-miterlimit: 10;
|
||
}
|
||
</style>
|
||
<title>Facebook</title>
|
||
<g>
|
||
<g>
|
||
<path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9 v67.5H135v-67.5h21.7L159,99.1z"></path>
|
||
</g>
|
||
</g>
|
||
<circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
|
||
</svg>
|
||
</a></li>
|
||
<li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube" target="_blank" rel="noopener noreferrer"><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" version="1.1" x="0px" y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
|
||
<title>Youtube</title>
|
||
<style type="text/css">
|
||
.st4 {
|
||
fill: none;
|
||
stroke: #FFFFFF;
|
||
stroke-width: 8;
|
||
stroke-miterlimit: 10;
|
||
}
|
||
|
||
.st5 {
|
||
fill: #FFFFFF;
|
||
}
|
||
</style>
|
||
<circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
|
||
<g transform="translate(0,-952.36218)">
|
||
<path class="st5" d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7 v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
|
||
</g>
|
||
</svg></a></li>
|
||
</ul>
|
||
</div>
|
||
<div class="col-lg-3 col-12">
|
||
<p class="address_footer text-white">National Library of Medicine<br />
|
||
<a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323" class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br />
|
||
Bethesda, MD 20894</a></p>
|
||
</div>
|
||
<div class="col-lg-3 col-12 centered-lg">
|
||
<p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br />
|
||
<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="text-white">FOIA</a><br />
|
||
<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
|
||
</div>
|
||
<div class="col-lg-3 col-12 centered-lg">
|
||
<p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br />
|
||
<a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br />
|
||
<a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
|
||
</div>
|
||
</div>
|
||
<div class="row">
|
||
<div class="col-lg-12 centered-lg">
|
||
<nav class="bottom-links">
|
||
<ul class="mt-3">
|
||
<li>
|
||
<a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
|
||
</li>
|
||
<li>
|
||
<a class="text-white" href="https://www.nih.gov/">NIH</a>
|
||
</li>
|
||
<li>
|
||
<a class="text-white" href="https://www.hhs.gov/">HHS</a>
|
||
</li>
|
||
<li>
|
||
<a class="text-white" href="https://www.usa.gov/">USA.gov</a>
|
||
</li>
|
||
</ul>
|
||
</nav>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
</section>
|
||
<script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>
|
||
<script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
<!--/.page-->
|
||
</div>
|
||
<!--/.wrap-->
|
||
</div><!-- /.twelve_col -->
|
||
</div>
|
||
<!-- /.grid -->
|
||
|
||
<span class="PAFAppResources"></span>
|
||
|
||
<!-- BESelector tab -->
|
||
|
||
|
||
|
||
<noscript><img alt="statistics" src="/stat?jsdisabled=true&ncbi_db=books&ncbi_pdid=book-part&ncbi_acc=NBK143547&ncbi_domain=mlprobe&ncbi_report=record&ncbi_type=fulltext&ncbi_objectid=&ncbi_pcid=/NBK143547/&ncbi_pagename=Non-covalent triazole-based inhibitors of the SARS main proteinase 3CLpro - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf&ncbi_bookparttype=chapter&ncbi_app=bookshelf" /></noscript>
|
||
|
||
|
||
<!-- usually for JS scripts at page bottom -->
|
||
<!--<component id="PageFixtures" label="styles"></component>-->
|
||
|
||
|
||
<!-- CE8B5AF87C7FFCB1_0191SID /projects/books/PBooks@9.11 portal104 v4.1.r689238 Tue, Oct 22 2024 16:10:51 -->
|
||
<span id="portal-csrf-token" style="display:none" data-token="CE8B5AF87C7FFCB1_0191SID"></span>
|
||
|
||
<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4209313/4212053/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
|
||
</html> |